XML 48 R27.htm IDEA: XBRL DOCUMENT
v3.24.3

Equity-Based Compensation | 12 Months Ended
--- | ---
Sep. 28, 2024
Share-Based Payment Arrangement [Abstract] |
Equity-Based Compensation | Equity-Based Compensation We have equity-based compensation plans that authorize the issuance of equity-based awards for shares of Class A and Class B common stock to directors, officers and key employees. Equity-based compensation grants are designed to reward long-term contributions to Moog and provide incentives for recipients to remain with Moog. We have an Employee Stock Purchase Plan ("ESPP") that allows for qualified employees (as defined in the plan) to purchase our common stock at a price equal to 85% of the fair market value at the lower of the beginning or the end of the semi-annual offering period. The 2014 Long Term Incentive Plan ("2014 Plan") authorizes the issuance of a total of 2,000,000 shares of either Class A or Class B common stock. The 2014 Plan is intended to provide a flexible framework that permits the development and implementation of a variety of equity-based programs that base awards on key performance metrics as well as align our long term incentive compensation with our peers and shareholder interests. During 2024, we granted awards in the form of performance-based restricted stock units ("PSUs"), time vested restricted stock units ("TVAs") and restricted stock awards ("RSAs"). The compensation cost for employee and non-employee director equity-based compensation programs for all current and prior year awards granted are as follows:
|  | 2024 |  | 2023 |  | 2022
Performance-based restricted stock units |  | $ | 5,994 |  |  | $ | 2,479 |  |  | $ | 1,718 |
Employee stock purchase plan |  | 3,718 |  |  | 2,956 |  |  | 2,521 |
Time vested restricted stock units |  | 3,223 |  |  | 2,461 |  |  | 1,423 |
Restricted stock awards |  | 1,151 |  |  | 1,102 |  |  | 850 |
Stock appreciation rights |  | 872 |  |  | 1,584 |  |  | 2,370 |
Total compensation cost before income taxes |  | $ | 14,958 |  |  | $ | 10,582 |  |  | $ | 8,882 |
Income tax benefit |  | $ | 2,091 |  |  | $ | 1,156 |  |  | $ | 970 |
Restricted Stock Units Performance-Based Awards PSU awards consist of shares of our stock which are payable upon the determination that we achieve certain established performance targets and can range from 0% to 200% of the targeted payout based on the actual results. PSU's granted in 2024 have a performance period of three years. The fair value of each PSU granted is equal to the fair market value of our common stock on the date of grant. PSUs granted generally have a cliff vesting schedule of three years; however, according to the grant agreements, if certain conditions are met, the employee (or beneficiary) may receive an amount of the award based on the terms and conditions of the agreement. PSUs are as follows:
Performance-Based Restricted Stock Units |  | Number of Awards |  | Weighted- Average Grant Date Fair Value
Nonvested at September 30, 2023 |  | 69,899 |  |  | $ | 84.25 |
Granted in 2024 |  | 40,388 |  |  | 126.20 |
Vested in 2024 |  | (29,418) |  |  | 84.23 |
Forfeited in 2024 |  | (4,098) |  |  | 96.59 |
Nonvested at September 28, 2024 |  | 76,771 |  |  | $ | 105.67 |
As of September 28, 2024, total unvested compensation expense associated with nonvested PSUs amounted to $4,511 and will be recognized over a weighted-average period of two years. The number of Class B shares to be issued for PS U awards granted in 2022 that vested based on the achievement of performance targets in 2024, will be approximately 40,900 share s. Time Vested Awards TVAs consist of shares of our stock which are payable over a vesting schedule determined at the time the award is granted. TVAs vest in equal fixed dollar tranches over the agreed upon vesting term beginning one year after the date of the grant and will settle using the fair market value of shares on the date of vesting of the tranche. Although it is our intention to settle vested amount in shares, we reserve the right to settle in cash at our discretion. TVAs are as follows:
Time Vested Restricted Stock Units |  | Number of Awards |  | Weighted- Average Fair Value
Nonvested at September 30, 2023 |  | 50,045 |  |  | $ | 112.72 |
Granted in 2024 |  | 40,353 |  |  | 127.96 |
Vested in 2024 |  | (20,396) |  |  | 126.20 |
Forfeited in 2024 |  | (2,932) |  |  | 157.53 |
Decrease due to fair value change in 2024 |  | (27,957) |  |  | n/a
Nonvested at September 28, 2024 |  | 39,113 |  |  | $ | 198.29 |
As of September 28, 2024, tota l unvested compensation expense associated with nonvested TVAs amounted to $4,865 and will be recognized over a weighted-average period of two years. The number of Class B shares to be issued for TVAs that are expected to vest in 2025 from time based service conditions is approximately 13,900 sh ares, based on our closing price of Class B common stock of $198.29 as of September 28, 2024. Restricted Stock Awards The fair value of each RSA granted is equal to the fair market value of our common stock on the date of grant. These shares vest and are issued upon grant. There were 9,117 RSAs granted and vested in 2024 at a price of $126.20 resulting in a fair value of the RSAs vested of $1,151. Employee Stock Purchase Plan Shares and the weighted-average price per share associated with the ESPP are as follows:
Employee Stock Purchase Plan |  | 2024 |  | 2023 |  | 2022
Shares issued |  | 126,355 |  |  | 155,704 |  |  | 139,121 |
Weighted-average price per share |  | $ | 105.18 |  |  | $ | 70.91 |  |  | $ | 67.91 |
Stock Appreciation Rights The fair value of SARs granted was estimated on the date of grant using the Black-Scholes option-pricing model. In 2024, there were no SARs granted. The number of shares received upon the exercise of a SAR is equal in value to the difference between the fair market value of the common stock on the exercise date and the exercise price of the SAR. The term of a SAR may not exceed ten years from the grant date. The exercise price of SARs and options, determined by a committee of the Board of Directors, may not be less than the fair value of the common stock on the grant date. SARs are as follows:
Stock Appreciation Rights |  | Number of Awards |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Life |  | Aggregate Intrinsic Value
Outstanding at September 30, 2023 |  | 701,510 |  |  | $ | 77.06 |  |  |  |  |
Exercised in 2024 |  | (149,643) |  |  | 72.88 |  |  |  |  |
Forfeited in 2024 |  | (1,849) |  |  | 81.11 |  |  |  |  |
Outstanding at September 28, 2024 |  | 550,018 |  |  | $ | 78.18 |  |  | 4.13 years |  | $ | 66,148 |
Exercisable at September 28, 2024 |  | 523,336 |  |  | $ | 77.94 |  |  | 3.98 years |  | $ | 63,072 |
The aggregate intrinsic value in the preceding tables represents the total pre-tax intrinsic value, based on our closing price of Class A common stock of $200.80 and Class B common stock of $198.29 as of September 28, 2024. That value would have been effectively received by the SAR holders had all SARs been exercised as of that date. The intrinsic value of awards exercised and fair value of awards vested are as follows:
Stock Appreciation Rights |  | 2024 |  | 2023 |  | 2022
Intrinsic value of SARs exercised |  | $ | 13,413 |  |  | $ | 5,596 |  |  | $ | 3,777 |
Total fair value of SARs vested |  | $ | 1,511 |  |  | $ | 2,426 |  |  | $ | 2,346 |
As of September 28, 2024, total unvested compensation expense associated with SARs amounted to $92 and will be recognized over a weighted-average period of less than one year.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration